Vivos Therapeutics (VVOS) Earnings Analysis
Vivos Therapeutics (VVOS) next reports earnings on 2026-08-18, consensus EPS -0.42 USD. Last quarter (2026-05-20) it missed with EPS -0.52 USD vs -0.45 USD est (-15.6%). It has beaten estimates in 4/8 recent quarters (50%). Trailing P/E -0.18.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does VVOS next report earnings?
| Next earnings date | 2026-08-18 |
|---|---|
| Consensus EPS estimate | -0.42 USD |
| Revenue estimate | 0.01B |
VVOS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-20 | -0.52 USD | -0.45 USD | -15.6% | Miss |
| 2026-04-15 | -0.58 USD | -0.495 USD | -17.2% | Miss |
| 2025-11-19 | -0.49 USD | -0.53 USD | +7.5% | Beat |
| 2025-08-19 | -0.55 USD | -0.27 USD | -103.7% | Miss |
| 2025-05-15 | -0.45 USD | -0.44 USD | -2.3% | Miss |
| 2025-03-31 | -0.28 USD | -0.43 USD | +34.9% | Beat |
| 2024-11-14 | -0.4 USD | -0.7 USD | +42.9% | Beat |
| 2024-08-14 | -0.6 USD | -1.05 USD | +42.9% | Beat |
Beat rate: 4/8 (50%) over reported quarters with consensus data.
VVOS valuation and analyst view
| Trailing P/E | -0.18 |
|---|---|
| Trailing EPS | -1.7164 USD |
| Price / book | -5.20 |
| Dividend yield | 0.00% |
| Market cap | 0.00B |
| Analyst consensus | Buy (5 buy / 0 hold / 0 sell) |
| Avg price target | 2.13 USD |
Related research pages
Frequently asked questions
When is Vivos Therapeutics (VVOS)'s next earnings date?
Vivos Therapeutics is next scheduled to report on 2026-08-18, with a consensus EPS estimate of -0.42 USD and revenue estimate of 0.01B.
Did VVOS beat earnings last quarter?
In its 2026-05-20 report, VVOS posted EPS of -0.52 USD versus a -0.45 USD estimate — a miss of 15.6%.
What is VVOS's earnings track record?
Over the last 8 reported quarters with consensus data, VVOS beat estimates 4 times (50%).
What is VVOS's current P/E ratio and EPS?
VVOS trades at a trailing P/E of -0.18 on trailing EPS of -1.716400342624067 USD.
What do analysts rate VVOS?
Analyst consensus is "Buy" across 5 ratings (0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 2.13 USD.